Printer Friendly

CannTrust Holdings names new interim CEO.

M2 PHARMA-July 26, 2019-CannTrust Holdings names new interim CEO


CannTrust Holdings Inc (TSX: TRST)(NYSE: CTST), a licensed producer of medical and recreational cannabis in Canada, announced yesterday that it has named special committee chair Robert Marcovitch as its new interim CEO.

Marcovitch will step down as a member of the special committee. He was most recently the president and CEO of K2 Sports, and earlier the chief executive officer at The Coleman Outdoor Company from 2011 until 2015, and chief executive officer and president of Ride Inc from 1994 to 1999.

Marcovitch said, 'Our first priority is to complete the remaining items of our investigation and bring the company's operations into full regulatory compliance. Implementing the necessary changes is essential to the interests of our medical patients, customers, shareholders and employees. CannTrust has a number of strengths it can draw upon to reset and rebuild, including industry-leading research, innovation and intellectual property.'

((Comments on this story may be sent to

COPYRIGHT 2019 Normans Media Ltd.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2019 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:M2 Pharma
Date:Jul 26, 2019
Previous Article:Gemphire signs definitive agreement with NeuroBo.
Next Article:PipelineRx names new CEO.

Terms of use | Privacy policy | Copyright © 2020 Farlex, Inc. | Feedback | For webmasters